StockWatch
·
Pharmaceuticals
Board Meeting1 Jul 2026, 03:26 pm

Sai Life Sciences Board Meeting on Aug 6 to Approve Q1 FY27 Results

AI Summary

Sai Life Sciences Ltd has announced that its Board of Directors will convene on August 6, 2026, to consider and approve the Un-audited Financial Results for the quarter ended June 30, 2026. The results will include both standalone and consolidated figures. Concurrently, the company has closed its trading window from July 1, 2026, to August 8, 2026, for directors, officials, and designated persons to prevent insider trading.

Key Highlights

  • Board meeting scheduled for August 6, 2026.
  • To approve Un-audited Financial Results for Q1 FY27.
  • Results will be standalone and consolidated.
  • Trading window closed from July 1 to August 8, 2026.